0

544220

CTLLAB

img img img img
No Data Available

Clinitech Laboratory Limited Share Price Update

As of the latest trading session, Clinitech Laboratory Limited is trading at ₹40.4, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹40.40 and ₹40.40 today. Over the past year, the stock has delivered a return of -8.18%. In the last month, it has returned -3.80%.

Investment Returns

Over 1 Month -3.80% Over 3 Months 14.77% Over 6 Months -8.39% Over 1 Year -8.18%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Clinitech Laboratory Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 9.20
  • P/E Ratio (TTM) 23.35
  • Beta 0.95
  • Book Value / share 38.68
  • Return on equity 5.49%
  • EPS (TTM) 1.52
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Clinitech Laboratory Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 8.23
Operating Expense 7.90
Net Profit 0.39
Net Profit Margin (%) 4.73
Earnings Per Share (EPS) 1.90
EBITDA 1.06
Effective Tax Rate (%) 29.09
Particulars MAR 2024 (Values in Cr)
Revenue 6.40
Operating Expense 5.93
Net Profit 0.37
Net Profit Margin (%) 5.78
Earnings Per Share (EPS) 2.37
EBITDA 1.04
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 6.35
Operating Expense 5.50
Net Profit 0.61
Net Profit Margin (%) 9.60
Earnings Per Share (EPS) 4.09
EBITDA 1.36
Effective Tax Rate (%) 29.06
Particulars MAR 2022 (Values in Cr)
Revenue 6.38
Operating Expense 5.76
Net Profit 0.51
Net Profit Margin (%) 7.99
Earnings Per Share (EPS) 3.42
EBITDA 1.14
Effective Tax Rate (%) 27.14
Particulars MAR 2021 (Values in Cr)
Revenue 4.55
Operating Expense 4.06
Net Profit 0.40
Net Profit Margin (%) 8.79
Earnings Per Share (EPS) 6.04
EBITDA 0.88
Effective Tax Rate (%) 25.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.69
ROE % 5.49
ROCE % 7.92
Total Debt to Total Equity 0.07
EBITDA Margin 12.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 21.12
ROE % 12.48
ROCE % 12.25
Total Debt to Total Equity 0.32
EBITDA Margin 16.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.87
ROE % 28.84
ROCE % 23.60
Total Debt to Total Equity 0.45
EBITDA Margin 21.73
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.32
ROE % 31.48
ROCE % 31.15
Total Debt to Total Equity 0.44
EBITDA Margin 17.87
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.86
ROE % 28.78
ROCE % 30.69
Total Debt to Total Equity 0.38
EBITDA Margin 19.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 10.71
Total Liabilities 10.71
Total Equity 8.83
Share Outstanding 0
Price to Book Ratio 1.04
Return on Assets (%) 3.68
Return on Capital (%) 4.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 5.60
Total Liabilities 5.60
Total Equity 3.54
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.61
Return on Capital (%) 8.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 6.03
Total Liabilities 6.03
Total Equity 2.38
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 10.16
Return on Capital (%) 17.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 3.68
Total Liabilities 3.68
Total Equity 1.84
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 13.90
Return on Capital (%) 18.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 2.73
Total Liabilities 2.73
Total Equity 1.39
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.72
Return on Capital (%) 20.88
Particulars MAR 2025 (Values in Cr)
Net Income 0.55
Cash from Operations -0.71
Cash from Investing -0.72
Cash from Financing 3.98
Net change in Cash 2.37
Free Cash Flow 0.44
Particulars MAR 2024 (Values in Cr)
Net Income 0.50
Cash from Operations -1.13
Cash from Investing 0.75
Cash from Financing 0.44
Net change in Cash -0.08
Free Cash Flow 0.06
Particulars MAR 2023 (Values in Cr)
Net Income 0.86
Cash from Operations 1.54
Cash from Investing -0.65
Cash from Financing 0.08
Net change in Cash 0.67
Free Cash Flow 1.82
Particulars MAR 2022 (Values in Cr)
Net Income 0.70
Cash from Operations 1.16
Cash from Investing -1.46
Cash from Financing 0.29
Net change in Cash -0.21
Free Cash Flow 2.67
Particulars MAR 2021 (Values in Cr)
Net Income 0.54
Cash from Operations 0.53
Cash from Investing 0.54
Cash from Financing -0.87
Net change in Cash 0.04
Free Cash Flow 0.71
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8359.75 61.45 12.68 120200.38 6680.00 8433.15
FORTIS MALAR HOSPITALS LIMITED 53.77 24.33 2.93 100.77 40.75 78.60
SHREE PACETRONIX LTD. 134.20 20.24 2.96 50.32 66.10 283.15
TRANSGENE BIOTEK LTD. 3.06 0.00 2.51 23.19 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8359.75 80.07 12.06 120200.38 6680.00 8433.15
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.50 0.00 -11.47 29.51 30.30 57.48
KOVAI MEDICAL CENTER & HO 5389.75 25.00 4.95 5896.39 5010.00 6725.00

Clinitech Laboratory Limited shareholding pattern

Holding
35.48%
64.2%
0.31%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Clinitech Laboratory Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
40.40 4.93 redarrow
red-green-graph indicator
5 Bearish
11 Bullish
  • 5 Days 39.40
  • 26 Days 39.20
  • 10 Days 39.40
  • 50 Days 39.70
  • 12 Days 39.30
  • 100 Days 42.70
  • 20 Days 39.20
  • 200 Days 53.50
40.40 PIVOT
First Support 40.40 First Resistance 40.40 Second Support 40.40 Second Resistance 40.40 Third Support 40.40 Third Resistance 40.40
RSI 52.18 ADX 12.01 MACD 0.17 Williams % R -50.18 Commodity Channel Index (CCI) 50.87
Date 2026-05-21 Week 1600.00 Same Day 2400.00 Month 2267.00
1 Year 0.96 3 Year 1.00
Over 1 Month
-3.80% down
Over 1 Year
-8.18% down
Over 3 Months
14.77% down
Over 3 Years
0.00% down
Over 6 Months
-8.39% down
Over 5 Years
0.00% down

Clinitech Laboratory Limited Corporate Actions

Top Gainers

Top Losers

Clinitech Laboratory Limited Share Price

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai. The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai. Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc.

The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018. Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests. Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient's symptoms and guide treatment decisions.

Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Imaging diagnosis or radiology involves imaging procedures such as X-rays and ultrasounds that help determine anatomical or physiological changes inside a patient's body, thus assisting doctors in diagnosing. It includes more complex tests such as CT scans, MRIs, and highly specialized PET-CT scans.

The Company issued and allotted 6,02,400 equity shares of Rs 10 each and raised funds, comprising a fresh issue of Rs 5.78 crores on 29 July, 2024.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Clinitech Laboratory Ltd?

Answer Field

Clinitech Laboratory Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 40.40 as on May 21 2026 12:00 AM.

What is the Market Cap of Clinitech Laboratory Ltd Share?

Answer Field

The market cap of Clinitech Laboratory Ltd for NSE ₹ 0.00 & for BSE ₹ 9.20 as on May 21 2026 12:00 AM.

What is the 52 Week High and Low of Clinitech Laboratory Ltd?

Answer Field

The 52 Week High and Low of Clinitech Laboratory Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 57.00 and ₹ 28.55.

What is 1 year return for Clinitech Laboratory Ltd?

Answer Field

The 1 year returns on the stock has been -8.18%.

What is the P/E Ratio of Clinitech Laboratory Ltd Share?

Answer Field

As on May 21 2026 12:00 AM the price-to-earnings (PE) ratio for Clinitech Laboratory Ltd share is 23.35.

What is the PB ratio of Clinitech Laboratory Ltd Share?

Answer Field

As on May 21 2026 12:00 AM, the price-to-book (PB) ratio for Clinitech Laboratory Ltd share is 38.68.

How to Buy Clinitech Laboratory Ltd Share?

Answer Field

You can trade in Clinitech Laboratory Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Clinitech Laboratory Ltd Share on Bajaj Broking App?

Answer Field

To buy Clinitech Laboratory Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Clinitech Laboratory Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|